Stay updated with the most recent articles and resources.
Recently, the Global Oncologist Network reported that a patient with advanced cardia cancer liver metastasis has successfully survived for three years after treatment with a...
The 2016 NCCN Clinical Guidelines for Gastric Cancer updated the systemic treatment plan for metastatic or locally advanced gastric cancer in the first edition (NCCN.2016.V1)....
The 2016 American Conference of Clinical Oncology (ASCO) is about to be held in Chicago as one of the most talked about academic conferences in...
According to the results of a large multicenter clinical trial led by scientists at the Dana Faber Cancer Research Center, after standard treatment fails, a...
Immunotherapy and cancer treatment In recent years, the popularity of immunotherapy in the field of oncology is continuing to rise. Lancet Oncol published the preliminary results...
According to statistics, patients with gastric cancer treated in the United States, Europe, and Japan are often recommended to use ramucirumab in combination with other...
What to do about drug resistance of non-small cell lung cancer targeted drugs, you want to know here Lung cancer is the cancer with the...
Lung cancer immunotherapy, lung cancer immunotherapy, lung cancer PD-1 treatment, and lung cancer PD-L1 treatment are all you want to know. In the past two...
Dong-Wan Kim scholars from the Seoul National University Hospital in South Korea will give an oral report on the special meeting of metastatic non-small cell...
Lung cancer and proton therapy The lungs are adjacent to some of the most sensitive and important organs and tissues, including the heart, esophagus, and...
Lung cancer is one of the most common causes of human death due to tumors, and its morbidity and mortality rate have ranked first in...
The results of the LUX-Lung 7 study show that a head-to-head Phase IIb clinical study compared afatinib and gefitinib in the treatment of tumors with...
We wish a speedy recovery for your loved ones.